Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Kallyope

Request full access

Identifying therapeutic opportunities involving the gut-brain axis

New York City, United StatesFounded 2015Biotech & Life Sciences

About Kallyope

Kallyope is a biotechnology startup based in New York City that operates in the healthcare sector. The company's primary focus is on the exploration and understanding of the complex network of interconnections between the gut, brain, and other organs in the human body. Kallyope's mission is to develop transformative therapeutics for a range of challenging diseases including diabetes, obesity, gut disorders, inflammatory diseases, migraines, allergies, and more.

The company serves a broad client base, primarily within the healthcare and pharmaceutical industries. These clients are typically organizations seeking innovative solutions for the treatment of various diseases. Kallyope's business model revolves around the use of its proprietary Klarity™ Platform. This platform integrates a range of leading technologies to discover and translate gut-brain biology, which is then used to develop new therapeutics.

Kallyope generates revenue through the development and commercialization of these therapeutics. The company's income comes from the sales of these treatments to healthcare providers and pharmaceutical companies. Additionally, Kallyope may also generate income through partnerships with other organizations in the healthcare sector, licensing its technologies, or through research grants.

The company prides itself on its culture of curiosity and connection, and its commitment to discovering new solutions to the world's most challenging diseases. Kallyope's operations are rooted in New York City, a hub for biotechnology innovation.

Source: Dealroom company data

Kallyope in the New York City ecosystem

Live from Dealroom

The Kallyope office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

19 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • Bill & Melinda Gates Foundation

Series A10 investors entered at this stage

Series B and later8 investors entered at this stage

Employees mapped 56 incl. 1 AI specialist
Founders Hidden — book a demo/100 quality score
Key operators 9 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Patents

Estimated portfolio value
$9M

13 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

See Kallyope on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.